id	sid	eid	entity	type
dti-1349	1	1	2013:7	CARDINAL
dti-1349	1	2	10.4137	CARDINAL
dti-1349	2	1	academica ltd.	ORG
dti-1349	4	1	thousands	CARDINAL
dti-1349	5	1	s h	ORG
dti-1349	7	1	2013:7 27	CARDINAL
dti-1349	7	2	md.	GPE
dti-1349	8	1	amin department	ORG
dti-1349	8	2	stamford university bangladesh	ORG
dti-1349	8	3	dhaka	GPE
dti-1349	8	4	bangladesh	GPE
dti-1349	9	1	xenobiotics	GPE
dti-1349	10	1	hundreds	CARDINAL
dti-1349	15	1	amin 28	PERSON
dti-1349	15	2	2013:7	CARDINAL
dti-1349	15	3	one	CARDINAL
dti-1349	15	4	first	ORDINAL
dti-1349	15	5	abc	ORG
dti-1349	15	6	xenobiotics	GPE
dti-1349	18	1	xenobiotics	NORP
dti-1349	18	2	two	CARDINAL
dti-1349	19	1	250	CARDINAL
dti-1349	19	2	1202	CARDINAL
dti-1349	20	1	hundreds	CARDINAL
dti-1349	24	1	1	CARDINAL
dti-1349	28	1	three	CARDINAL
dti-1349	29	1	2	CARDINAL
dti-1349	29	2	atp hydrolysis	PERSON
dti-1349	30	1	1	CARDINAL
dti-1349	32	1	2013:7 29	CARDINAL
dti-1349	32	2	p-gp.2 p-gp	ORG
dti-1349	32	3	three	CARDINAL
dti-1349	33	1	first	ORDINAL
dti-1349	34	1	first	ORDINAL
dti-1349	35	1	second	ORDINAL
dti-1349	36	1	second	ORDINAL
dti-1349	36	2	cypa4	PERSON
dti-1349	36	3	abc	ORG
dti-1349	37	1	two	CARDINAL
dti-1349	37	2	abc	ORG
dti-1349	38	1	third	ORDINAL
dti-1349	39	1	1	CARDINAL
dti-1349	40	1	2	CARDINAL
dti-1349	41	1	1	CARDINAL
dti-1349	42	1	first	ORDINAL
dti-1349	42	2	tamoxifen	ORG
dti-1349	46	1	second	ORDINAL
dti-1349	46	2	valspodar	ORG
dti-1349	46	3	psc 833	ORG
dti-1349	46	4	dofequidar	NORP
dti-1349	46	5	first	ORDINAL
dti-1349	47	1	3a4	CARDINAL
dti-1349	47	2	abc	ORG
dti-1349	48	1	third	ORDINAL
dti-1349	48	2	laniquidar	PERSON
dti-1349	48	3	nsc-38721	DATE
dti-1349	48	4	biricodar	GPE
dti-1349	48	5	elacridar	PERSON
dti-1349	48	6	tariquidar	PERSON
dti-1349	48	7	xr9576	GPE
dti-1349	49	1	first	ORDINAL
dti-1349	49	2	second	ORDINAL
dti-1349	50	1	amin 30	PERSON
dti-1349	50	2	2013:7	CARDINAL
dti-1349	51	1	anti-p	NORP
dti-1349	52	1	uic2	ORG
dti-1349	52	2	99	CARDINAL
dti-1349	53	1	uic2	ORG
dti-1349	53	2	uic2	PERSON
dti-1349	53	3	only 10% to 40%	PERCENT
dti-1349	54	1	psc 833	ORG
dti-1349	55	1	uic2	ORG
dti-1349	65	1	compounds.32,33	PRODUCT
dti-1349	65	2	third	ORDINAL
dti-1349	66	1	al34	PRODUCT
dti-1349	66	2	xr9576	GPE
dti-1349	67	1	abc	ORG
dti-1349	68	1	10 mg/kg	QUANTITY
dti-1349	68	2	3.4%	PERCENT
dti-1349	68	3	41.3%	PERCENT
dti-1349	69	1	drug.10	LOC
dti-1349	69	2	bbb	ORG
dti-1349	70	1	al36	PRODUCT
dti-1349	70	2	10-fold	CARDINAL
dti-1349	71	1	sugie	ORG
dti-1349	71	2	al37	ORG
dti-1349	72	1	bbb	ORG
dti-1349	73	1	bbb	ORG
dti-1349	74	1	kemper et al38	ORG
dti-1349	74	2	5-fold	CARDINAL
dti-1349	74	3	gf120918	PERSON
dti-1349	74	4	third	ORDINAL
dti-1349	74	5	2013:7	CARDINAL
dti-1349	75	1	half	CARDINAL
dti-1349	76	1	half	CARDINAL
dti-1349	82	1	abc	ORG
dti-1349	83	1	abc	ORG
dti-1349	83	2	microorganisms.41–43 p-gp	PERSON
dti-1349	91	1	al52	PRODUCT
dti-1349	93	1	actions.52 leitner et	PERSON
dti-1349	93	2	al49	PRODUCT
dti-1349	93	3	third	ORDINAL
dti-1349	95	1	10-fold	CARDINAL
dti-1349	98	1	elacridar.48	GPE
dti-1349	103	1	32	CARDINAL
dti-1349	103	2	2013:7	CARDINAL
dti-1349	104	1	anti-p	NORP
dti-1349	106	1	anti-p	NORP
dti-1349	106	2	mrk-16	GPE
dti-1349	106	3	al29	PERSON
dti-1349	106	4	uic2	ORG
dti-1349	106	5	first	ORDINAL
dti-1349	107	1	uic2	ORG
dti-1349	107	2	vivo.29 danson	GPE
dti-1349	107	3	al57	ORG
dti-1349	107	4	al59	GPE
dti-1349	107	5	valspodar	ORG
dti-1349	109	1	m109r	ORG
dti-1349	111	1	half	CARDINAL
dti-1349	116	1	first	ORDINAL
dti-1349	127	1	1	CARDINAL
dti-1349	127	2	srivalli kmr	PERSON
dti-1349	127	3	lakshmi pk	PERSON
dti-1349	128	1	braz j pharm sci	ORG
dti-1349	129	1	2	CARDINAL
dti-1349	129	2	fj	NORP
dti-1349	132	1	2011;50(1):161–78. 3	CARDINAL
dti-1349	132	2	edwards je	PERSON
dti-1349	132	3	alcorn j	ORG
dti-1349	132	4	anderson bd	PERSON
dti-1349	132	5	mcnamara pj	PERSON
dti-1349	133	1	antimicrob	PERSON
dti-1349	134	1	2005;49(4	CARDINAL
dti-1349	134	2	1626–8	CARDINAL
dti-1349	134	3	4	CARDINAL
dti-1349	134	4	melaine n	PERSON
dti-1349	134	5	liénard mo	GPE
dti-1349	135	1	lejeune h	GPE
dti-1349	135	2	jégou b.	PERSON
dti-1349	135	3	mouse	PERSON
dti-1349	138	1	beaulieu e	PERSON
dti-1349	138	2	r. p	PERSON
dti-1349	139	1	j. 1997;326(pt 2):539–44	PERSON
dti-1349	140	1	6	CARDINAL
dti-1349	140	2	ma jd	PERSON
dti-1349	140	3	tsunoda sm	PERSON
dti-1349	140	4	bertino js jr	PERSON
dti-1349	140	5	trivedi m	PERSON
dti-1349	140	6	beale kk	PERSON
dti-1349	141	1	clin pharmacokinet	ORG
dti-1349	142	1	2010;49(4):223–37	TIME
dti-1349	143	1	2013:7	CARDINAL
dti-1349	143	2	33 7	DATE
dti-1349	144	1	fortuna	PERSON
dti-1349	144	2	alves g	PERSON
dti-1349	144	3	falcao a.	PERSON
dti-1349	144	4	123	CARDINAL
dti-1349	146	1	2011	DATE
dti-1349	146	2	8	CARDINAL
dti-1349	149	1	1994;77(7):1071–81	CARDINAL
dti-1349	150	1	lin jh	PERSON
dti-1349	150	2	yamazaki m. role	PERSON
dti-1349	151	1	clin pharmacokinet	PERSON
dti-1349	152	1	2003;42(1):59–98	CARDINAL
dti-1349	153	1	10	CARDINAL
dti-1349	154	1	varma mvs	PERSON
dti-1349	154	2	panchagnula r. p	PERSON
dti-1349	156	1	11	CARDINAL
dti-1349	157	1	fj	NORP
dti-1349	157	2	liu r	PERSON
dti-1349	157	3	romsicki y.	PERSON
dti-1349	159	1	2001;12(3):257–65.	DATE
dti-1349	160	1	12	CARDINAL
dti-1349	161	1	martins	PERSON
dti-1349	164	1	2010;30(3):829–35	CARDINAL
dti-1349	164	2	13	CARDINAL
dti-1349	165	1	bansal t	PERSON
dti-1349	165	2	jaggi m	PERSON
dti-1349	165	3	khar rk	PERSON
dti-1349	165	4	talegaonkar s.	GPE
dti-1349	166	1	j pharm pharm sci	ORG
dti-1349	167	1	2009;12(1):46–78	CARDINAL
dti-1349	167	2	14	DATE
dti-1349	168	1	matsuo h	ORG
dti-1349	170	1	15	CARDINAL
dti-1349	171	1	horowitz	PERSON
dti-1349	171	2	zalipsky s	PERSON
dti-1349	172	1	clin	ORG
dti-1349	173	1	2000;6(5	CARDINAL
dti-1349	174	1	1949–57	CARDINAL
dti-1349	175	1	16	CARDINAL
dti-1349	176	1	mazel m	PERSON
dti-1349	176	2	clair p	ORG
dti-1349	178	1	2001;12(2):107–16	CARDINAL
dti-1349	179	1	17	CARDINAL
dti-1349	180	1	shapiro ab	PERSON
dti-1349	180	2	ling v.	PERSON
dti-1349	180	3	33342	DATE
dti-1349	182	1	1997;53(4	CARDINAL
dti-1349	182	2	587–96	DATE
dti-1349	182	3	18	CARDINAL
dti-1349	182	4	drori s	PERSON
dti-1349	182	5	eytan	GPE
dti-1349	184	1	1995;228(3):1020–9.	DATE
dti-1349	185	1	robert j	PERSON
dti-1349	185	2	jarry c. multidrug	PERSON
dti-1349	187	1	2003;46(23):4805–17	CARDINAL
dti-1349	188	1	20	CARDINAL
dti-1349	189	1	lomovskaya	PERSON
dti-1349	189	2	o	DATE
dti-1349	189	3	bostian ka	PERSON
dti-1349	191	1	2006;71(7):910–8	CARDINAL
dti-1349	192	1	21	CARDINAL
dti-1349	193	1	lomovskaya	PERSON
dti-1349	193	2	o	DATE
dti-1349	193	3	watkins wj	PERSON
dti-1349	195	1	nat rev drug discov	PERSON
dti-1349	196	1	2007;6(1):56–65	CARDINAL
dti-1349	197	1	22	CARDINAL
dti-1349	198	1	kuppens	PERSON
dti-1349	198	2	jewell rc	PERSON
dti-1349	199	1	topotecan	NORP
dti-1349	200	1	clin	PERSON
dti-1349	201	1	2007;13(11	CARDINAL
dti-1349	201	2	3276–85	DATE
dti-1349	202	1	23	CARDINAL
dti-1349	203	1	wagner p	PERSON
dti-1349	203	2	ibrahim n	PERSON
dti-1349	205	1	2005;104(4):682–91	CARDINAL
dti-1349	205	2	24	CARDINAL
dti-1349	205	3	malingré mm	PERSON
dti-1349	205	4	beijnen jh	PERSON
dti-1349	209	1	25	CARDINAL
dti-1349	210	1	thomas h, coley	PERSON
dti-1349	213	1	2003;10(2):159–65	CARDINAL
dti-1349	214	1	26	CARDINAL
dti-1349	215	1	krishna	PERSON
dti-1349	215	2	mayer ld	PERSON
dti-1349	217	1	eur j pharm sci	ORG
dti-1349	218	1	27	CARDINAL
dti-1349	219	1	newman mj	PERSON
dti-1349	219	2	rodarte jc	PERSON
dti-1349	219	3	benbatoul	GPE
dti-1349	221	1	2000;60(11):2964–72	CARDINAL
dti-1349	222	1	28	CARDINAL
dti-1349	223	1	nokihara h	ORG
dti-1349	223	2	sone s.	PERSON
dti-1349	224	1	nippon	GPE
dti-1349	225	1	1997;55(5):1128–34	CARDINAL
dti-1349	226	1	japanese	NORP
dti-1349	227	1	29	CARDINAL
dti-1349	228	1	goda k	PERSON
dti-1349	229	1	uic2	ORG
dti-1349	231	1	30	CARDINAL
dti-1349	232	1	lee ch	PERSON
dti-1349	232	2	hwang sj	PERSON
dti-1349	232	3	kr30031	GPE
dti-1349	234	1	2003;20(1):24–30	CARDINAL
dti-1349	236	1	banerjee	GPE
dti-1349	236	2	dasgupta a.	PERSON
dti-1349	236	3	crl-1605	DATE
dti-1349	238	1	2000;67(16):2011–16	CARDINAL
dti-1349	239	1	32	CARDINAL
dti-1349	240	1	eytan	GPE
dti-1349	240	2	regev r	PERSON
dti-1349	240	3	oren g	PERSON
dti-1349	244	1	33	CARDINAL
dti-1349	245	1	döppenschmitt	PERSON
dti-1349	247	1	1999;88(10):1067–72.	DATE
dti-1349	248	1	34	CARDINAL
dti-1349	249	1	kwak jo	PERSON
dti-1349	249	2	lee	PERSON
dti-1349	249	3	lee gs	PERSON
dti-1349	249	4	mdr1 (abcb1	ORG
dti-1349	250	1	eur	CARDINAL
dti-1349	251	1	2010;627(1–3):92–8	CARDINAL
dti-1349	252	1	35	DATE
dti-1349	253	1	batrakova ev	PERSON
dti-1349	253	2	miller dw	PERSON
dti-1349	253	3	li s	PERSON
dti-1349	253	4	alakhov vy	PERSON
dti-1349	253	5	kabanov av	PERSON
dti-1349	254	1	pluronic	PERSON
dti-1349	256	1	2001;296(2):551–7	TIME
dti-1349	257	1	36	CARDINAL
dti-1349	258	1	van asperen j	PERSON
dti-1349	259	1	833	CARDINAL
dti-1349	261	1	1997;76(9):1181–3	CARDINAL
dti-1349	262	1	37	CARDINAL
dti-1349	262	2	sugie m	ORG
dti-1349	262	3	asakura e	PERSON
dti-1349	262	4	zhao yl	PERSON
dti-1349	262	5	mrp2	ORG
dti-1349	263	1	antimicrob	PERSON
dti-1349	264	1	38	CARDINAL
dti-1349	265	1	kemper em	ORG
dti-1349	265	2	van zandbergen ae	PERSON
dti-1349	266	1	clin	PERSON
dti-1349	267	1	2003;9(7):2849–55	CARDINAL
dti-1349	268	1	39	CARDINAL
dti-1349	269	1	kerr dj	PERSON
dti-1349	269	2	graham j	PERSON
dti-1349	272	1	1986;18(3):239–42. 40	DATE
dti-1349	272	2	m. natural	PERSON
dti-1349	274	1	41	CARDINAL
dti-1349	275	1	gibbons s	PERSON
dti-1349	275	2	kaatz gw	PERSON
dti-1349	277	1	j antimicrob	PERSON
dti-1349	278	1	2003;51(1	CARDINAL
dti-1349	279	1	42	CARDINAL
dti-1349	280	1	poole k. efflux-	PERSON
dti-1349	281	1	j antimicrob	PERSON
dti-1349	282	1	2005;56(1):20–51	PERSON
dti-1349	282	2	43	DATE
dti-1349	282	3	normark bh	PERSON
dti-1349	282	4	normark s.	PERSON
dti-1349	284	1	2002;252(2):91–106	CARDINAL
dti-1349	285	1	44	DATE
dti-1349	286	1	poole k. mechanisms	PERSON
dti-1349	288	1	2002;92:55s–64	PERSON
dti-1349	289	1	45	CARDINAL
dti-1349	290	1	wright	PERSON
dti-1349	291	1	curr opin	PERSON
dti-1349	293	1	46	DATE
dti-1349	294	1	huet aa	PERSON
dti-1349	294	2	mendiratta k	PERSON
dti-1349	294	3	kaatz gw	PERSON
dti-1349	297	1	2008;154(pt 10):3144–53	CARDINAL
dti-1349	298	1	47	CARDINAL
dti-1349	299	1	rodríguez jc	PERSON
dti-1349	299	2	garcía	GPE
dti-1349	299	3	ruiz m	PERSON
dti-1349	299	4	royo g.	PERSON
dti-1349	300	1	2007;53(6	CARDINAL
dti-1349	301	1	397–401	CARDINAL
dti-1349	302	1	48	DATE
dti-1349	303	1	levy sb	PERSON
dti-1349	303	2	marshall b.	PERSON
dti-1349	304	1	nat med	PERSON
dti-1349	305	1	2004;10(suppl 12):s122–9	DATE
dti-1349	305	2	49	CARDINAL
dti-1349	306	1	leitner	PERSON
dti-1349	307	1	nemeth j	PERSON
dti-1349	308	1	third	ORDINAL
dti-1349	309	1	j antimicrob	PERSON
dti-1349	310	1	2011;66(4	ORG
dti-1349	311	1	50	CARDINAL
dti-1349	312	1	lee vj	PERSON
dti-1349	313	1	pat antiinfect	PERSON
dti-1349	314	1	2006;1(2	DATE
dti-1349	314	2	157–75	DATE
dti-1349	315	1	51	CARDINAL
dti-1349	316	1	renau te	PERSON
dti-1349	318	1	1999;42(24):4928–31	CARDINAL
dti-1349	319	1	amin 34	PERSON
dti-1349	319	2	2013:7 52	CARDINAL
dti-1349	320	1	michot jm	PERSON
dti-1349	320	2	leclercq mp	PERSON
dti-1349	320	3	tulkens	GPE
dti-1349	320	4	van bambeke f. influence	PERSON
dti-1349	322	1	2003;47(3):1047–51	CARDINAL
dti-1349	323	1	53	CARDINAL
dti-1349	324	1	mazel m	PERSON
dti-1349	324	2	clair p	ORG
dti-1349	326	1	2001;12(2):107–16	CARDINAL
dti-1349	327	1	54	DATE
dti-1349	327	2	raub tj	PERSON
dti-1349	330	1	2005;3(1):3–25	CARDINAL
dti-1349	331	1	55	CARDINAL
dti-1349	333	1	adv drug deliv	ORG
dti-1349	334	1	2002;54(5):631–51	PERSON
dti-1349	334	2	56	CARDINAL
dti-1349	334	3	soma ce	PERSON
dti-1349	335	1	couvreur p. reversion	ORG
dti-1349	337	1	2000;21(1):1–7	CARDINAL
dti-1349	338	1	57	DATE
dti-1349	339	1	danson s	PERSON
dti-1349	339	2	alakhov	PERSON
dti-1349	341	1	2004;90(11	CARDINAL
dti-1349	341	2	2085–91	DATE
dti-1349	342	1	58	DATE
dti-1349	343	1	batrakova ev	PERSON
dti-1349	346	1	1996;74(10):1545–52	CARDINAL
dti-1349	347	1	59	CARDINAL
dti-1349	347	2	liliemark j	PERSON
dti-1349	348	1	psc 833	ORG
dti-1349	349	1	j clin oncol	PERSON
dti-1349	350	1	2000;18(9):1837–44	CARDINAL